Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles

Lung cancer is a formidable challenge in clinical practice owing to its metastatic nature and resistance to conventional treatments. The codelivery of anticancer agents offers a potential solution to overcome resistance and minimize systemic toxicity. The encapsulation of these agents within nanostr...

Descripción completa

Detalles Bibliográficos
Autores principales: Elzayat, Ehab M., Sherif, Abdelrahman Y., Nasr, Fahd A., Attwa, Mohamed W., Alshora, Doaa H., Ahmad, Sheikh F., Alqahtani, Ali S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419431/
https://www.ncbi.nlm.nih.gov/pubmed/37570067
http://dx.doi.org/10.3390/ma16155364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419431/
https://www.ncbi.nlm.nih.gov/pubmed/37570067
http://dx.doi.org/10.3390/ma16155364

Ejemplares similares